AGIOS PHARMACEUTICALS, INC. (AGIO) Gross margin 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
88.3%FY2025 · since FY2016: 100.0% → 88.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 88.3% | -0.3 pp |
| FY2024 | 88.6% | -0.7 pp |
| FY2023 | 89.3% | +1.2 pp |
| FY2022 | 88.0% | — |
| FY2019 | 98.9% | +0.4 pp |
| FY2018 | 98.5% | -1.5 pp |
| FY2017 | 100.0% | +0.0 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AGIO financial trends
AGIO RevenueAGIO Net incomeAGIO Net marginAGIO Gross profitAGIO Operating incomeAGIO Operating marginAGIO Operating cash flowAGIO Free cash flowAGIO Capital expendituresAGIO Return on equityAGIO Stock buybacksAGIO Dividends paidAGIO Total assetsAGIO Total liabilitiesAGIO Shareholders’ equityAGIO overview →